DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
TALADEGIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis
Smoothened homolog antagonist
TALADEGIB
×
Maximum Phase:
1
First Approval:
None
UNII:
QY8BWX1LJ5
Molecule Type:
Small molecule
Molecular Formula:
C26H24F4N6O
Molecular Weight:
512.51
AlogP:
4.93
PSA:
67.15
HBD:
0.0
HBA:
#RotB:
4.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
AR-12
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
3-phosphoinositide dependent protein kinase-1 inhibitor
AR-12
×
Maximum Phase:
1
First Approval:
None
UNII:
EX3O2Q61UV
Molecule Type:
Small molecule
Molecular Formula:
C26H19F3N4O
Molecular Weight:
460.46
AlogP:
5.76
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
4.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
BI113823
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Bradykinin B1 receptor antagonist
BI113823
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
INDOLE-3-CARBINOL
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Tobacco Use Disorder; Obesity
Unknown
INDOLE-3-CARBINOL
×
Maximum Phase:
1
First Approval:
None
UNII:
C11E72455F
Molecule Type:
Small molecule
Molecular Formula:
C9H9NO
Molecular Weight:
147.18
AlogP:
1.66
PSA:
36.02
HBD:
2.0
HBA:
#RotB:
1.0
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TEMSAVIR
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TEMSAVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
4B6J53W8N3
Molecule Type:
Small molecule
Molecular Formula:
C24H23N7O4
Molecular Weight:
473.49
AlogP:
1.63
PSA:
126.31
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TEGLARINAD CHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Nicotinamide phosphoribosyltransferase inhibitor
TEGLARINAD CHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D6V5QYX9MZ
Molecule Type:
Small molecule
Molecular Formula:
C30H43Cl2N5O8
Molecular Weight:
672.61
AlogP:
3.91
PSA:
145.77
HBD:
2.0
HBA:
#RotB:
23.0
Source:
BMS-794833
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-794833
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WX-554
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
WX-554
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOSULPIRIDE
1
Small molecule
Investigational
Unknown
Unknown
Dyspepsia; Psychomotor Agitation; Psychotic Disorders
Dopamine D2 receptor antagonist
LEVOSULPIRIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
JTG7R315LK
Molecule Type:
Small molecule
Molecular Formula:
C15H23N3O4S
Molecular Weight:
341.43
AlogP:
0.56
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LY-3200882
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
LY-3200882
×
Maximum Phase:
1
First Approval:
None
UNII:
19HY34R6UN
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O3
Molecular Weight:
435.53
AlogP:
4.67
PSA:
94.32
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CONTELTINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
ALK tyrosine kinase receptor inhibitor
CONTELTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
URX2UMQ8XV
Molecule Type:
Small molecule
Molecular Formula:
C32H45N9O3S
Molecular Weight:
635.84
AlogP:
3.84
PSA:
126.99
HBD:
4.0
HBA:
#RotB:
10.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
GCC-4401C
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GCC-4401C
×
Maximum Phase:
1
First Approval:
None
UNII:
I636054KKA
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClN5O3S
Molecular Weight:
419.89
AlogP:
2.51
PSA:
86.27
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BMS-387032
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms
Cyclin-dependent kinase 2 inhibitor
BMS-387032
×
Maximum Phase:
1
First Approval:
None
UNII:
9979I93686
Molecule Type:
Small molecule
Molecular Formula:
C17H24N4O2S2
Molecular Weight:
380.54
AlogP:
3.66
PSA:
80.05
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PF-04455242
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Depressive Disorder
Unknown
PF-04455242
×
Maximum Phase:
1
First Approval:
None
UNII:
Y3530Z78QD
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O2S
Molecular Weight:
372.53
AlogP:
3.88
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
7.0
Source:
N6022
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis
Alcohol dehydrogenase class III inhibitor
N6022
×
Maximum Phase:
1
First Approval:
None
UNII:
80LIU5P95D
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4O3
Molecular Weight:
414.47
AlogP:
3.75
PSA:
103.14
HBD:
2.0
HBA:
#RotB:
7.0
Source:
METHYL P-TOLUENESULFONYL-L-ARGININATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYL P-TOLUENESULFONYL-L-ARGININATE
×
Maximum Phase:
1
First Approval:
None
UNII:
1H7BKF44U1
Molecule Type:
Small molecule
Molecular Formula:
C14H22N4O4S
Molecular Weight:
342.42
AlogP:
-0.13
PSA:
136.87
HBD:
3.0
HBA:
#RotB:
8.0
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOHEXANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CYCLOHEXANE
×
Maximum Phase:
1
First Approval:
None
UNII:
48K5MKG32S
Molecule Type:
Small molecule
Molecular Formula:
C6H12
Molecular Weight:
84.16
AlogP:
2.34
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CROBENETINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CROBENETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Q72DWI2G4C
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.91
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ASP-3026
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms
ALK tyrosine kinase receptor inhibitor
ASP-3026
×
Maximum Phase:
1
First Approval:
None
UNII:
HP4L6MXF10
Molecule Type:
Small molecule
Molecular Formula:
C29H40N8O3S
Molecular Weight:
580.76
AlogP:
3.77
PSA:
115.82
HBD:
2.0
HBA:
#RotB:
9.0
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIGOTINDISULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms
Unknown
INDIGOTINDISULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
X7OI7JF73P
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O8S2
Molecular Weight:
422.4
AlogP:
1.31
PSA:
166.94
HBD:
4.0
HBA:
#RotB:
2.0
Source:
1
2
…
74
75
76
77
78
79
80
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA